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ABSTRACT In unstimulated mammalian cells and in Sac-
charomyces cerevisiae, themousemammary tumor virus (MMTV)
promoter is silent and organized into positioned nucleosomes,
one of which encompasses the binding sites for glucocorticoid
receptor (GR) and nuclear factor I (NFI). Glucocorticoid induc-
tion in vivo involves a functional synergism between GR and NFI
and simultaneous occupancy of the promoter sites for both
proteins that cannot be reproduced on naked DNA. The role of
chromatin in the process of induction was investigated by ma-
nipulating the nucleosome density in yeast strains carrying a
regulated histone H4 gene. Following depletion of nucleosomes,
independent transactivation by NFI or by GR, as well as binding
of the individual proteins to the MMTV promoter, were en-
hanced, in agreement with a repressive function of nucleosomes.
In contrast, NFI-dependent hormone induction of the promoter
and the simultaneous binding of receptor and NFI were com-
promised by nucleosome depletion. This effect could be partly
mediated by a cryptic binding site for the receptor that is
functional only in the nucleosomal context. Thus, positioned
nucleosomes do not only account for constitutive repression of
the MMTV promoter, but also participate in induction by
mediating cooperative binding and functional synergism be-
tween GR and NFI.
The organization of eukaryotic DNA in chromatin is usually
seen as an obstacle for binding of transcription factors to their
cognate sequences and is supposed to participate in constitu-
tive repression of genes as well as in gene induction by
derepession (1, 2). However, nucleosomes can also fulfill a
positive architectural function by organizing the DNA se-
quences so as to permit interactions between factors bound to
otherwise distant sites (3–5). A rapidly growing number of
reports document the participation of chromatin dynamics in
the process of gene regulation (for a recent review, see ref. 6),
and direct interactions between transcription factors and chro-
matin components have been described (7, 8). Although in
most cases these interactions are involved in transcriptional
repression, a positive effect in particular contexts cannot be
excluded (9).
To analyze the participation of nucleosomes in gene expres-
sion, we have chosen the mouse mammary tumor virus
(MMTV) promoter which is regulated by steroid hormones
through an interaction of the hormone receptors with a
complex array of hormone responsive elements (HREs) lo-
cated between 2190 and 280 (see ref. 10 and references
therein). Hormonal induction of the MMTV promoter re-
quires not only binding of the hormone receptors to the HREs
but also of other transcription factors to adjacent promoter
sequences (11). In particular, a functional synergism with
members of the ubiquitous nuclear factor I (NFI) family bound
to a site immediately downstream of the HREs is essential for
strong induction in vivo (12, 13). Conventional mechanisms
invoking cooperative DNA binding are insufficient to explain
this synergism between glucocorticoid receptor (GR) and NFI,
since both proteins compete for binding to naked promoter
DNA (13). In cell-free transcription assays with naked DNA
templates, NFI acts as a strong constitutive transcription factor
but does not synergize with hormone receptors (11, 14). Thus,
the mechanism underlying the functional synergism between
GR and NFI during hormonal induction remains obscure.
In mice fibroblasts (15), in unstimulated breast epithelial
cells (16), as well as when introduced into Saccharomyces
cerevisiae (17), the MMTV promoter is silent and organized
into positioned nucleosomes. Although the precise positioning
is still controversial (18), we find a dominant frame that
encompasses the binding sites for GR and NFI in yeast and in
mammalian cells (16, 17). A similar nucleosome organization
is found in chromatin reconstitution experiments with MMTV
promoter fragments and core histone octamers (19–22). While
GR can access the most distal and the most proximal receptor
binding sites, NFI cannot bind to the MMTV promoter
incorporated in positioned nucleosomes (19–21), which could
be the basis for repression of the promoter in the absence of
hormone (17, 23). In hormone-induced cells the nucleosome
over the promoter is remodeled and all binding sites for
receptors as well as the NFI site are occupied, suggesting that
mechanisms exist in vivo to permit simultaneous binding of
factors to the surface of a nucleosome (16). On the other hand,
attempts to demonstrate cooperative binding of GR and NFI
to reconstituted nucleosomes have been unsuccessful, and the
function of the nucleosome remains unclear (refs. 19 nnd 20;
and unpublished results).
To provide genetic evidence for a possible role of nucleo-
somes in transcriptional control of the MMTV promoter, we
have manipulated the nucleosome density in S. cerevisiae by
modulating transcription of the histone H4 gene (24). If
nucleosomes participate in basal and induced MMTV tran-
scription by determining access of transcription factors, chang-
ing the density of nucleosomes on the promoter should influ-
ence its activity in the absence and in the presence of hormone.
Here we show that nucleosome depletion of yeast strains
carrying the MMTV promoter leads to a better accessibility of
the promoter for the individual factors, accompanied by a
more efficient transactivation by either NFI, NFI–herpes
simplex virus activator protein VP16 (VP16), or GR, when
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these factors are expressed individually. These findings sup-
port a repressive role of nucleosomes in MMTV promoter
function. However, the functional synergism between NFI and
GR required for strong hormonal induction, is compromised
under conditions of nucleosome depletion, as expected if
nucleosomes participate actively in the induction process by
facilitating the cooperation between GR and NFI. Possible
biochemical mechanisms underlying this positive role of nu-
cleosomes are discussed, taking into consideration a new
HRE, which is inactive in transient transfections but contrib-
utes to induction in a nucleosomal context.
MATERIALS AND METHODS
Yeast Strains and Plasmids. Strains SChY50 (MATa, ade2,
his3, leu2, lys2, trp1, ura3, thr2, tyr2, hhf1::HIS3,
hhf2::leu2D::ADE2ypUK421 (CEN TRP1 GAL-HHF2) was gen-
erated by disrupting the wild-type LEU2 allele present in strain
PKY899 (25) with a leu2D:ADE2 construct, and replacing plas-
mid pUK499 by pUK421 (26) following a plasmid shuffle tech-
nique. Strain SChY50 is therefore isogenic to UKY403 (26)
except that it is Leu2 and Ade1, and it carries a single histone H4
gene that is controlled by the GAL1 promoter. Strain SChY51
was constructed similarly to SChY50 but contains the H4–2 gene
controlled by its own promoter.
pLGZ-MMTV (17) was the MMTV–lacZ reporter plasmid
used in this work. pSCh105 (23) is a truncated version of the
reporter, lacking theHRE region of theMMTVpromoter, and
pSCh136 is homologous to pLGZ–MMTV, but containing
several mutations in the HRE5. pSX26.1 is an HRE-CYC1–
lacZ reporter (27).
To express NFI we used pAA–CTF2 (28), a vector for the
NFI variant CTF2, derived from pAAH5. Plasmid pSCh124
was constructed by inserting a DNA fragment coding for a
NFI–VP16 chimera (23) in the expression vector p425MET25
(29). pSCh129 (17) is an expression vector for rat GR.
The HRE5 mutation was constructed by exchanging five
positions known to be protected by GR in dimethyl sulfate
(DMS) footprinting experiments (30). The wild-type MMTV
promoter sequence between 2160 and 2140 (protected po-
sitions shown in boldface type) was changed from GATGT-
GAGATAAGTGGTTTCC to GATGTAAAACAAGTAATT-
TCC. This mutations eliminated binding of GR to this site in
vitro (data not shown).
Growth and Nucleosome-Depletion Conditions. Yeast
strains transformed with the appropriate set of plasmids
were grown at 308C in selective medium containing galactose
as carbon source. Before reaching stationary phase, cells
were washed, transferred to rich medium (yeast extracty
peptone) containing glucose or galactose, and incubated
further at 308C for 6 h. For hormone-induction, 0.1 mM
deacylcortivazol (DAC) or ethanol for control samples were
included during this last incubation. After cooling on ice,
cells were used for plasmid-superhelicity analysis, micrococ-
cal nuclease digestion, or assayed for b-galactosidase activity
(31).
Genomic Footprinting. For genomic footprinting, strain
SChY50, transformed with the appropriate plasmids, was
grown at 308C in selective medium containing galactose as
carbon source. Before reaching stationary phase, cells were
washed and transferred to rich medium containing glucose or
galactose. After 1 h of further incubation at 308C, cultures were
treated with 1 mMDAC or with ethanol for 30 min. Cells were
then rapidly harvested, treated with DMS, and processed as
described (17). Piperidine-digested DNA samples were then
analyzed by linear PCR (17).
RESULTS
Nucleosome Depletion Facilitates Access to the NFI Site. To
study the influence of low nucleosome density on the activity of
the MMTV promoter we made use of a yeast strain in which the
endogenous histone H4 genes have been deleted and a GAL1-
driven histone H4 gene has been introduced (24). Into this yeast
strain we incorporated a MMTV-driven lacZ gene (Fig. 1A).
Incubation in glucose medium reduced the nucleosomal density
of episomal DNA in this yeast strain, as demonstrated by topo-
isomer analysis of plasmid DNA (Fig. 1B). Approximately 40%
of the negative superhelical density found in the presence of
galactose is lost during nucleosome depletion in the presence of
glucose. At the same time, the MMTV promoter sequences
became more sensitive to digestion by micrococcal nuclease, as
expected for a region partially depleted of nucleosomes (Fig. 1C).
This effect is not due to the change in carbon source, which did
not influence strains with wild-type H4 genes.
FIG. 1. Repression of histone H4 gene results in nucleosome
depletion over the MMTV promoter. (A) Schematic representation of
histone H4-mediated nucleosome depletion, according to the method
developed by Grunstein and collaborators (26). (B) Superhelicity of
episomes carrying the MMTV–lacZ reporter in SChY50 cells grown in
galactose- or glucose-containing media (17). The modal value of the
distribution of topoisomers is indicated by arrows. The difference
between cells grown in galactose (Gal) and in glucose (Glu) corre-
sponds to 40% nucleosome depletion. Superhelicity analysis was
performed as described (32) but hybridizing with an Escherichia coli
lacZ probe. (C) Micrococcal nuclease (MNase) sensitivity of MMTV
promoter in normal (galactose) or histone H4-depleted chromatin
(glucose) of SChY50 cells (17). Note that in glucose medium the
nuclease digestion is more effective and leads to appearance of shorter
polynucleosomes and mononucleosomes. MMTV sensitivity to micro-
coccal nuclease was assayed as described (17) with a probe extending
from 2173 to 278 in the MMTV promoter.
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We have previously shown that in yeast, like in metazoan
cells, the MMTV promoter positions a nucleosome which
encompasses the HREs and the NFI binding site (17). Under
conditions of nucleosome depletion the NFI binding site on the
MMTV promoter was more accessible to NFI or a NFI–VP16
chimera, as demonstrated by the enhanced activity of the
reporter. The effect observed with NFI was weak because this
particular transactivator acts poorly in yeast (28), but it was
specific for the nucleosome-depleted strain, as incubation in
glucose medium of yeast strains expressing a nonregulated
histone H4 gene had no effect on reporter activity (Fig. 2A).
When the more potent chimeric transactivator NFI–VP16 was
used instead, the effect of nucleosome depletion was more
evident and could be quantitated reproducibly. The MMTV
reporter was activated 4-fold more efficiently by NFI–VP16
when the nucleosome density was reduced by treatment with
glucose. Moreover, genomic footprinting experiments showed
partial occupancy of the NFI site on the promoter in the
absence of hormone, only under conditions of nucleosome
depletion but not at normal nucleosome density (see below and
Fig. 4B). Therefore, the physiological nucleosome density
contributes to maintaining the NFI site on the MMTV pro-
moter unaccessible for factor binding.
The HRE Region Is Required for Restricting Access to the
NFI Site. To ascertain whether access to the NFI site is
determined by the sequences encompassing the HREs, we
analyzed the response to nucleosome depletion of a truncated
MMTV promoter lacking the sequences between 2236 and
277, but containing an intact NFI binding site and core
promoter elements. This reporter is already more active in the
presence of NFI or NFI–VP16 at normal nucleosome density
(23), and its activity is not markedly influenced by nucleosome
depletion (Fig. 2B; note that the ordinate scale is one order of
magnitude higher than in Fig. 2A). These findings exclude
effects of nucleosome depletion due to changes in the levels or
the activity of NFI. The levels of NFI mRNA measured by
Northern blot analysis were not altered by glucose treatment
of yeast strains carrying a regulated histone H4 gene (data not
shown). In contrast with the wild-type promoter (17), indirect
end-labeling experiments did not reveal positioning of nucleo-
somes over the residual MMTV promoter in this truncated
construction (data not shown and ref. 23). We conclude that
nucleosomes positioned by the region containing the HREs
(23) are at least partly responsible for constitutive repression
of the MMTV promoter, and that transactivation by NFI is
enhanced by nucleosome depletion.
Nucleosome Depletion Improves Transactivation by GR of
HRE-Containing Reporters. To test whether nucleosome de-
FIG. 2. Nucleosome depletion derepresses NFI-dependent tran-
scription of MMTV promoter. (A) Yeast strains with the histone H4
gene under its own promoter or under galactose (Gal) control, and
containing a complete MMTV–lacZ reporter with a positioned nu-
cleosome, were transformed with an expression vector for NFI,
NFI–VP16, or empty vector (23). b-Galactosidase activities of cultures
switched from galactose to glucose (Glu) or kept in galactose are
shown. (B) A similar yeast strain with the histone H4 gene under
galactose control and carrying a truncated MMTV–lacZ reporter,
depicted at the bottom, was assayed as in A. Note the difference in
scale between A and B.
FIG. 3. Nucleosome depletion does not inhibit GR function but hinders the synergistic activation of MMTV promoter by GR and NFI. (A) A
yeast strain with the histone H4 gene under Gal control was transformed with the episomal GRE–lacZ reporter described in the scheme, together
with an expression vector for rat GR (27). Cultures were incubated with ligand or vehicle after switching cells from galactose (Gal) to glucose (Glu)
or keeping them in galactose. b-Galactosidase activities are shown. (B Left) b-Galactosidase activities obtained in experiments similar to those
described in A but using the MMTV–lacZ reporter depicted in Fig. 2A. (Right) Results obtained from a yeast strain with the histone H4 gene driven
by its own promoter. (C) Functional synergism between GR and NFI. Synergism is defined as the ratio of the activity found in the presence of
GRyDAC and NFI over the sum of the activity found with GRyDAC in the absence of NFI and the activity measured with NFI in the absence
of GRyDAC (Fig. 2A Right). (D) Similar experiments to those described in B but in strains additionally transformed with an NFI-expressing vector.
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pletion had an effect on GR function we used a reporter
containing several HREs in front of the yeast CYC1 core
promoter (27) (Fig. 3A). Constitutive activity as well as
GR-mediated induction of this hybrid promoter by the ago-
nistic ligand DAC were enhanced several fold by nucleosome
depletion (Fig. 3A). These results demonstrate that GR can act
more efficiently at low nucleosome density on an array of
HREs linked to a yeast promoter.
To confirm that this conclusion applies also to the MMTV
promoter, we analyzed the effect GR and DAC on MMTV
transcription in the absence of NFI. Under these conditions,
the observed induction was low, as shown previously (17). As
with the CYC1 promoter, transactivation by ligand activated
GR is enhanced several fold under conditions of nucleosome
depletion (Fig. 3B). Nucleosome depletion did not influence
the levels of GR mRNA (data not shown), and glucose
treatment of yeast strains expressing the wild-type histone H4
gene did not change the activity of the MMTV promoter (Fig.
3B). Thus, in the absence of NFI, GR binding and transacti-
vation on the MMTV promoter do not require normal nu-
cleosome density, but on the contrary are enhanced on pro-
moters partially depleted of nucleosomes.
Nucleosome Depletion Compromises the Synergism Be-
tween GR and NFI Needed for Strong Induction. In yeast
strains with physiological histone levels, the absence of NFI or
a mutation of the NFI binding site reduces hormone induction
of the MMTV promoter by 80%, demonstrating that GR
action involves a synergism with NFI (17). Having shown that
the individual actions of NFI and GR are improved at low
nucleosome density, we next asked whether the synergism
between the two factors was similarly affected. Unexpectedly,
nucleosome depletion resulted in suboptimal induction of
transcription from the MMTV promoter in the presence of
NFI, whereas glucose per se had no effect in yeast strains with
a wild-type histone H4 gene (Fig. 3D). In the yeast strain used
for these experiments the functional synergism between GR
andNFI was 4- to 5-fold at normal nucleosome density and was
completely abolished by nucleosome depletion (Fig. 3C). The
residual induction seen in glucose medium is very similar to
that observed in the absence of NFI (compare Fig. 3 B Left
with D Left) and likely reflects in part the improved GR
function at low nucleosome density (see Fig. 3 A and B).
In genomic footprinting experiments, occupancy of the NFI
site was enhanced after nucleosome depletion in the absence
of hormone (Fig. 4A, compare lanes 6 and 8). Quantitation of
FIG. 4. Genomic footprinting over the MMTV promoter. (A Left)
At low nucleosome density (glucose; Glu) there is a better access of
GR to the HRE5 (marked by a triangle on the right) in response to
ligand. The asterisks on the left mark two bands detected under all
conditions, which do not correspond to guanines in the DNA se-
quence. Their identity is unknown. (Right) In the presence of NFI, at
low nucleosome density, a cluster of guanines within the NFI site
(triangle) is more protected before hormone treatment (lane 8) than
after hormone induction (lane 7). The relevant guanine on HRE4 is
marked by a triangle. (B) PhosphorImager quantitation of the pro-
tection over the NFI site and the HRE2, -3, and -4, derived from three
experiments similar to that shown in A Right. The values were
normalized for variations in loading using the strong band within the
octamer distal site (OctD) at the bottom of the gel. The mean and
standard deviation are shown.
FIG. 5. HRE5 participates in synergistic induction by ligand acti-
vated GR. (A) Influence of mutations in the HRE5 site on the activity
of the MMTV promoter. The mutation is described in Materials and
Methods. (B) Schematic array of sites: distance betweenHRE5 and the
NFI site. (C) Hypothetical model of GR and NFI bound to their
cognate sites on the surface of a nucleosome. A GR (bold) bound to
HRE5 would be close to the DNA-bound NFI. The model and the
positions of the cis elements are not drawn to scale.
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the gel yields 51% protection following nucleosome depletion
(Fig. 4B). At normal nucleosome density protection over the
NFI site after hormone induction is only 50% (Fig. 4B)
because the response of the yeast population is not homoge-
neous (17). Nevertheless, following hormone treatment, pro-
tection over the NFI site was reduced by nucleosome depletion
to insignificant values (Fig. 4B), suggesting a competition
between receptor and NFI at low nucleosome density (Fig. 4A,
lanes 5 and 7). Due to known difficulties in footprinting DNA
bound GR in vivo (16), the effects of ligand and of nucleosome
depletion on the occupancy of the four classical HREs were
less significant and did not allow safe conclusions.
ANewHREParticipates in Induction by LigandActivatedGR.
In the original experiments on GR binding to the MMTV
promoter using DMS footprinting in vitro, a site was detected
between position 2156 and 2144, which when mutated did not
show a phenotype in transient transfection assays (30, 33).
Therefore, this site was considered a cryptic HRE. However, in
genomic footprinting experiments inmammalian cells (16) and in
yeast cells (17), changes in DMS sensitivity were found in the
guanines over this sequence upon hormone induction, suggesting
that hormone dependent interactions were taking place on this
site (labeled HRE5 in Fig. 4A). Therefore, we tested the influ-
ence of mutations within this site on the induction of the MMTV
reporter in yeast. In agreement with the footprint data, we found
that mutations which interfere with GR binding to HRE5 (data
not sown) have a significant effect on promoter activity, which is
reduced to 25% of the activity of the wild-type promoter (Fig.
5A). The effect of the HRE5 mutation is much less pronounced
in the absence of NFI (Fig. 5A).
DISCUSSION
NFI binds with high affinity to theMMTV promoter DNA and
transactivates efficiently under cell-free conditions (13, 14).
However, like in nucleosome depleted yeast cells, neither
DNA binding cooperativity nor synergism between GR and
NFI have been detected on naked MMTV DNA. NFI binding
to the promoter is rather hindered by bound GR (13). In intact
cells with chromosomal copies of MMTV, the promoter is
positioned in a nucleosome and free of factors in the absence
of hormones (15, 16, 34), though there is abundant NFI in the
cell nucleus (35). Hormone induction leads to simultaneous
occupancy of the HREs, and the NFI site, on the surface of a
positioned nucleosome (16). These observations suggested
that the organization of theMMTV promoter in chromatin not
only represses the promoter prior to induction but could also
play a positive role in hormonal activation (16). The results
reported here support this hypothesis. The low activity of the
MMTV promoter in the absence of hormone probably reflects
the inability of NFI to access its cognate site when this is
included in a positioned nucleosome (19–21, 36), because
repression is partly relieved by nucleosome depletion. De-
repression by nucleosome depletion has been reported for
other inducible yeast promoters exhibiting nucleosome posi-
tioning, such as the PHO5 promoter, though in this case the
main contribution may be an enhanced accessibility of the
TATA box region (37). In the MMTV promoter this cannot be
the only explanantion, because deletion of the HREs, leaving
the NFI site and the TATA box intact, eliminates most of the
nucleosome depletion effect. Prior to hormone induction,
occupancy of the NFI site is enhanced upon nucleosome
depletion, indicating that occlusion of this site by nucleosomes
participates in constitutive repression of the promoter.
Hormone induction of a yeast promoter linked to HREs is
improved by lowering the nucleosome density. The same is true
for the MMTV promoter in the absence of NFI, suggesting that
nucleosomes do actually hinder the NFI-independent activation
of the promoter by liganded receptor. This effect could be partly
due to a better binding of the receptor to the nucleosome-
depleted promoter. It is known that GR binds to in vitro recon-
stitutedMMTV nucleosomes with 3- to 8-fold lower affinity than
to the same sequences as freeDNA (19, 20, 38). However, amore
efficient interaction of theDNA-bound receptor with the general
transcription factors could also contribute to the better induc-
ibility observed at low nucleosomal density.
In marked contrast to the separate functions of NFI andGR,
their cooperation on theMMTV promoter is not enhanced but
rather abrogated by nucleosome depletion. The inhibition of
the synergism between the two transcription factors under
conditions of nucleosome depletion suggests that the func-
tional interaction between GR and NFI may depend on the
organization of the MMTV promoter sequence on the surface
of a rearranged nucleosome. The elimination of synergism
between the two factors was complete although the average
nucleosome depletion was ,50%. Two possible mechanisms
could contribute to this strong effect. The MMTV promoter
could be particularly sensitive to the inhibition of histone H4
synthesis and become depleted of nucleosomes to a much
higher extent than the average DNA. There are no indications
for this nucleosome being unusually unstable in vitro (19, 20),
but the in vivo stability of this nucleosome is unknown.
Alternatively, under conditions of partial nucleosome deple-
tion there could be a competition between GR and NFI for
binding to the MMTV promoter. Given that NFI is a weak
transactivator in the absence of GR but binds the promoter
DNA with high affinity, a competition could lead to an
inhibition of the NFI-independent activation by liganded GR,
and thus reduce the final level of activity. The genomic
footprinting results support this notion. In the absence of GR,
nucleosome depletion leads to higher occupancy of their NFI
site. In contrast, depriving the MMTV promoter of nucleo-
somes reduces the occupancy of the NFI site in the presence
of GR and ligand. Thus, nucleosome depletion reproduces
within the cell nucleus the situation previously described on
naked MMTV DNA in vitro.
There are few well defined examples for a positive role of
nucleosomes in transcription. Deletion of the N-terminal tail of
histone H4 reduces transactivation of the GAL1 promoter sig-
nificantly, but this effect has been related to a change in nucleo-
some positioning that influences access to the TATA box (39).
One interesting model may be the enhancer of the rat albumin
gene, which in liver cells contains a positioned nucleosome, on
which surface the relevant transcription factors can interact with
their cognate DNA sequences (40). There is, however, little
evidence for an active function of the nucleosome in this context.
How could the organization of the MMTV promoter se-
quence on the surface of a nucleosome facilitate transcription
factor binding and functional synergism? A simple cooperat-
ivity between factors binding to adjacent sites (41, 42) is not
sufficient to account for the synergism between GR and NFI,
as it cannot be reproduced in the test tube with isolated
MMTV nucleosomes and purified GR and NFI (20). It is likely
that the observed synergism involves additional activities. A
possible candidate is the ubiquitous SWIySNF complex (43),
which has been shown to facilitate GR induction in yeast and
in animal cells (44, 45). However, no evidence for targeting of
the SWIySNF complex to the MMTV promoter has been
produced, and other nucleosome remodeling activities have
been recently identified which, in principle, could also partic-
ipate in MMTV induction (46).
Once the nucleosome has been remodeled, there are two
simple ways in which its organization could facilitate interac-
tions between GR and NFI. It is possible that the curvature of
DNA on the surface of the histone octamer may contribute to
the synergism between receptors and NFI. Hormone receptors
bound to HREs induce DNA bending toward the protein
(47–49), and this bending may interfere with binding of NFI
to an adjacent site. The wrapping of the double helix around
the histone octamer bends the DNA in the opposite direction.
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This could not only account for the reduced affinity of
hormone receptors for HREs organized in nucleosomes (38,
50), but could also prevent steric hindrance between GR and
NFI by counteracting the receptor-induced DNA bending.
The nucleosome structure could also facilitate the func-
tional interaction between GR and NFI simply by the close
proximity of the two DNA superhelical turns on the surface of
the nucleosome. This topology should bring distant HREs
close to the NFI site. In this respect it is interesting that the
cryptic HRE located around position 2150, now named
HRE5, would come in close proximity to the NFI site on the
surface of a nucleosome (Fig. 5C). Contrary to the other four
HREs, HRE5 is not functional in transient transfection ex-
periments with cultured cells (ref. 32 and unpublished results),
probably reflecting the fact that in such experiments the
promoter is not properly organized in chromatin (51). How-
ever, HRE5 participates in the synergistic activation by GR in
yeast chromatin as demonstrated by the strong negative effect
of mutations which abolish GR binding to this site. We also
find that hormone induction leads to partial occupancy of the
HRE5 both in yeast cells and animal cells (refs. 16 and 17 and
unpublished results). Therefore, we have identified a hormone
receptor binding site that seems to be fully functional only in
the context of a nucleosomally organized MMTV promoter.
Apart from these simple mechanisms, it is also possible that
structural components of chromatin could be directly involved
in the interaction with sequence-specific transcription factors.
In yeast, the N-terminal tails of histones H3 and H4 are
required for activation of certain genes (32) and they have been
shown to directly interact with other factors, for instance in the
process of telomere silencing (7). Moreover, an interaction of
NFI with the globular domain of histone H3 has been reported
(9). If the hormone induced nucleosome rearrangement would
involve the dissociation of a histone 2Ayhistone 2B dimer, it
could expose a previously masked surface of histone H3 for an
interaction with NFI. This would provide an attractive mech-
anism for an active participation of nucleosome components in
the functional synergism between GR ad NFI. However, this
explanation seems unlikely as the amino acid residues of NFI
involved in interaction with histone H3 are located in the very
C-terminal region of CTF1 (9), which is missing in the variant
of NFI used for our experiments, namely CTF2 (9). While
CTF2 interacts very weakly if at all with histone H3 (9), in
terms of synergism with GR on the MMTV promoter, the two
forms of NFI, CTF-1 and CTF-2, are indistinguishable (17). Of
course, we cannot exclude that other components of the
nucleosome do interact directly with NFI. The availability of
yeast strains with mutations in the core histones and in other
factors involved in chromatin dynamics should allow a genetic
approach to these questions.
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